Modeling-Enabled Systems Nutritional Immunology

Frontiers in Nutrition

Volumn 3, Issue , 2016, Pages

  Verma, Meghna ^a   Hontecillas, Raquel ^a   Abedi, Vida ^a   Leber, Andrew ^a   Tubau Juni, Nuria ^a   Philipson, Casandra ^b   Carbo, Adria ^b   Bassaganya Riera, Josep ^a  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^b BIOTHERAPEUTICS INC   (United States)

Author keywords

big data; complex systems; computational modeling; informatics; nutrition; nutritional immunology; systems biology

Indexed keywords

EID: 84989318199     PISSN: None     EISSN: 2296861X     Source Type: Journal    
DOI: 10.3389/fnut.2016.00005     Document Type: Review

References (132)

1. Beisel WR. The history of nutritional immunology. J Nutr Immunol (1991) 1(1):5–40.
2. Beisel WR. History of nutritional immunology: introduction and overview1. J Nutr (1992) 122(3S):591.
3. Satyaraj E. Emerging paradigms in immunonutrition. Top Companion Anim Med (2011) 26(1):25–32.10.1053/j.tcam.2011.01.00421435623
4. Greicius G, Arulampalam V, Pettersson S. A CLA’s act: feeding away inflammation. Gastroenterology (2004) 127(3):994–6.10.1053/j.gastro.2004.07.038
5. Bendich A, Chandra RK. Micronutrients and immune functions. Ann N Y Acad Sci (1990) 587:3–320.10.1111/j.1749-6632.1990.tb00144.x
6. Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr (1997) 66(2):460S–3S.9250133
7. Afacan NJ, Fjell CD, Hancock RE. A systems biology approach to nutritional immunology-focus on innate immunity. Mol Aspects Med (2012) 33(1):14–25.10.1016/j.mam.2011.10.013
8. Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease – the gut-brain axis and environmental factors. Nat Rev Neurol (2015) 11(11):625–36.10.1038/nrneurol.2015.197
9. Kim PS, Levy D, Lee PP. Modeling and simulation of the immune system as a self-regulating network. Methods Enzymol (2009) 467:79–109.10.1016/S0076-6879(09)67004-X19897090
10. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature (2011) 474(7351):327–36.10.1038/nature1021321677749
11. Dave M, Higgins PD, Middha S, Rioux KP. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res (2012) 160(4):246–57.10.1016/j.trsl.2012.05.00322683238
12. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A (1998) 95(12):6578–83.10.1073/pnas.95.12.65789618454
13. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature (2007) 449(7164):804–10.10.1038/nature0624417943116
14. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe (2008) 3(4):213–23.10.1016/j.chom.2008.02.01518407065
15. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med (2009) 1(6):ra14–6.10.1126/scitranslmed.300032220368178
16. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 444(7122):1027–31.10.1038/nature0541417183312
17. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature (2014) 505(7484):559–63.10.1038/nature1282024336217
18. Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Hontecillas R. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One (2012) 7(4):e34676.10.1371/journal.pone.003467622511958
19. Muegge BD, Kuczynski J, Knights D, Clemente JC, González A, Fontana L, et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science (2011) 332(6032):970–4.10.1126/science.119871921596990
20. Daniel H, Moghaddas Gholami A, Berry D, Desmarchelier C, Hahne H, Loh G, et al. High-fat diet alters gut microbiota physiology in mice. ISME J (2014) 8(2):295–308.10.1038/ismej.2013.15524030595
21. Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N, et al. Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort study. Gastroenterology (2003) 125(1):32–9.10.1016/S0016-5085(03)00701-7
22. Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R, et al. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR gamma to suppress colitis. PLoS One (2012) 7(2):e31238.10.1371/journal.pone.0031238
23. Marion-Letellier R, Déchelotte P, Iacucci M, Ghosh S. Dietary modulation of peroxisome proliferator-activated receptor gamma. Gut (2009) 58(4):586–93.10.1136/gut.2008.16285919017686
24. Bassaganya-Riera J, Hontecillas R. Dietary CLA and n-3 PUFA in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care (2010) 13(5):569.10.1097/MCO.0b013e32833b648e
25. Borenstein E. Computational systems biology and in silico modeling of the human microbiome. Brief Bioinform (2012) 13(6):769–80.10.1093/bib/bbs02222589385
26. Viladomiu M, Hontecillas R, Yuan L, Lu P, Bassaganya-Riera J. Nutritional protective mechanisms against gut inflammation. J Nutr Biochem (2013) 24(6):929–39.10.1016/j.jnutbio.2013.01.00623541470
27. Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med (2015) 7(307):ra152–307.10.1126/scitranslmed.aab227126424567
28. Fonseca DM, Hand TW, Han SJ, Gerner MY, Glatman Zaretsky A, Byrd AL, et al. Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity. Cell (2015) 163(2):354–66.10.1016/j.cell.2015.08.03026451485
29. Hooper LV. Do symbiotic bacteria subvert host immunity? Nat Rev Microbiol (2009) 7(5):367–74.10.1038/nrmicro211419369952
30. Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol (2003) 3(1):63–72.10.1038/nri98212511876
31. Trop TK. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol (2014) 20(33):11505.10.3748/wjg.v20.i33.1150525206258
32. Bassaganya-Riera J, DiGuardo M, Viladomiu M, de Horna A, Sanchez S, Einerhand AW, et al. Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease. J Nutr (2011) 141(7):1318–25.10.3945/jn.111.139022
33. Quigley EM. Prebiotics and probiotics their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract (2012) 27(2):195–200.10.1177/088453361142392622127952
34. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res (2013) 54(9):2325–40.10.1194/jlr.R03601223821742
35. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med (2011) 62:361–80.10.1146/annurev-med-012510-17550521226616
36. Sakamoto M, Benno Y. Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as Parabacteroides distasonis gen. nov., comb. nov., Parabacteroides goldsteinii comb. nov. and Parabacteroides merdae comb. nov. Int J Syst Evol Microbiol (2006) 56(7):1599–605.10.1099/ijs.0.64192-016825636
37. Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, et al. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol (2011) 163(2):250–9.10.1111/j.1365-2249.2010.04286.x21087444
38. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell (2012) 148(6):1258–70.10.1016/j.cell.2012.01.03522424233
39. Johnson R. Immune and endocrine regulation of food intake in sick animals. Domest Anim Endocrinol (1998) 15(5):309–19.10.1016/S0739-7240(98)00031-99785035
40. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 9(1):46–56.10.1038/nrn229718073775
41. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci (2001) 933(1):222–34.10.1111/j.1749-6632.2001.tb05827.x
42. Palmer CS, Ostrowski M, Balderson B, Christian N, Crowe SM. Glucose metabolism regulates T cell activation, differentiation, and functions. Front Immunol (2015) 6:1.10.3389/fimmu.2015.0000125657648
43. Pearce EL, Poffenberger MC, Chang CH, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science (2013) 342(6155):1242454.10.1126/science.124245424115444
44. Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol (2011) 186(6):3299–303.10.4049/jimmunol.100361321317389
45. Guerrant RL, Oriá RB, Moore SR, Oriá MO, Lima AA. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev (2008) 66(9):487–505.10.1111/j.1753-4887.2008.00082.x18752473
46. Philipson CW, Bassaganya-Riera J, Viladomiu M, Pedragosa M, Guerrant RL, Roche JK, et al. The role of peroxisome proliferator-activated receptor gamma in immune responses to enteroaggregative Escherichia coli infection. PLoS One (2013) 8(2):e57812.10.1371/journal.pone.0057812
47. Philipson CW, Bassaganya-Riera J, Hontecillas R. Animal models of enteroaggregative Escherichia coli infection. Gut Microbes (2013) 4(4):281–91.10.4161/gmic.24826
48. Bolick DT, Kolling GL, Moore JH, II de Oliveira LA, Tung K, Philipson C, et al. Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea. Gut Microbes (2014) 5(5):618–27.10.4161/19490976.2014.96964225483331
49. Wu D, Meydani SN. Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J Leukoc Biol (2008) 84(4):900–14.10.1189/jlb.010802318596135
50. Ross AC. Vitamin A and retinoic acid in T cell-related immunity. Am J Clin Nutr (2012) 96(5):1166S–72S.10.3945/ajcn.112.03463723053562
51. Haase H, Rink L. Zinc signals and immune function. Biofactors (2014) 40(1):27–40.10.1002/biof.111423804522
52. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr (2004) 24:277–98.10.1146/annurev.nutr.24.012003.13245415189122
53. Calder PC. Very long chain omega-3 (n-3) fatty acids and human health. Eur J Lipid Sci Technol (2014) 116(10):1280–300.10.1002/ejlt.201400025
54. Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr (2012) 142(3):592S–9S.10.3945/jn.111.15525922279140
55. Calder PC. Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enteral Nutr (2015) 39(1 Suppl):18S–32S.10.1177/014860711559598026177664
56. Hontecillas R, Wannemeulher MJ, Zimmerman DR, Hutto DL, Wilson JH, Ahn DU, et al. Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid. J Nutr (2002) 132(7):2019–27.12097686
57. Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, et al. Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology (2004) 127(3):777–91.10.1053/j.gastro.2004.06.049
58. Bassaganya-Riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr (2006) 25(3):454–65.10.1016/j.clnu.2005.12.00816698153
59. Evans NP, Misyak SA, Schmelz EM, Guri AJ, Hontecillas R, Bassaganya-Riera J. Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARγ. J Nutr (2010) 140(3):515–21.10.3945/jn.109.115642
60. Bassaganya-Riera J, Pogranichniy RM, Jobgen SC, Halbur PG, Yoon KJ, O’Shea M, et al. Conjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression. J Nutr (2003) 133(10):3204–14.14519812
61. Bassaganya-Riera J, Hontecillas R, Zimmerman DR, Wannemuehler MJ. Long-term influence of lipid nutrition on the induction of CD8+ responses to viral or bacterial antigens. Vaccine (2002) 20(9):1435–44.10.1016/S0264-410X(01)00465-0
62. Bassaganya-Riera J, Hontecillas R, Horne WT, Sandridge M, Herfarth HH, Bloomfeld R, et al. Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn’s disease. Clin Nutr (2012) 31(5):721–7.10.1016/j.clnu.2012.03.00222521469
63. Abedi V, Lu P, Hontecillas R, Verma M, Vess G, Philipson C, et al. Phase III placebo-controlled, randomized clinical trial with synthetic Crohn’s disease patients to evaluate treatment response. Emerging Trends in Computational Biology, Bioinformatics, and Systems Biology – Systems & Applications. Elsevier/MK (2016) (in press).
64. Guri AJ, Hontecillas R, Si H, Liu D, Bassaganya-Riera J. Dietary abscisic acid ameliorates glucose tolerance and obesity-related inflammation in db/db mice fed high-fat diets. Clin Nutr (2007) 26(1):107–16.10.1016/j.clnu.2006.07.00817000034
65. Guri AJ, Hontecillas R, Bassaganya-Riera J. Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration. Clin Nutr (2010) 29(6):824–31.10.1016/j.clnu.2010.02.00920236740
66. Guri AJ, Misyak SA, Hontecillas R, Hasty A, Liu D, Si H, et al. Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall. J Nutr Biochem (2010) 21(12):1178–85.10.1016/j.jnutbio.2009.10.00320092994
67. Bassaganya-Riera J, Guri AJ, Lu P, Climent M, Carbo A, Sobral BW, et al. Abscisic acid regulates inflammation via ligand-binding domain-independent activation of peroxisome proliferator-activated receptor γ. J Biol Chem (2011) 286(4):2504–16.10.1074/jbc.M110.160077
68. Hontecillas R, Roberts PC, Carbo A, Vives C, Horne WT, Genis S, et al. Dietary abscisic acid ameliorates influenza-virus-associated disease and pulmonary immunopathology through a PPARγ-dependent mechanism. J Nutr Biochem (2013) 24(6):1019–27.10.1016/j.jnutbio.2012.07.01022995385
69. Magnone M, Ameri P, Salis A, Andraghetti G, Emionite L, Murialdo G, et al. Microgram amounts of abscisic acid in fruit extracts improve glucose tolerance and reduce insulinemia in rats and in humans. FASEB J (2015) 29(12):4783–93.10.1096/fj.15-27773126243865
70. Kubena KS, McMurray DN. Nutrition and the immune system: a review of nutrient-nutrient interactions. J Am Diet Assoc (1996) 96(11):1156–64.10.1016/S0002-8223(96)00297-0
71. Lacroix S, Lauria M, Scott-Boyer MP, Marchetti L, Priami C, Caberlotto L. Systems biology approaches to study the molecular effects of caloric restriction and polyphenols on aging processes. Genes Nutr (2015) 10(6):58.10.1007/s12263-015-0508-926608884
72. Gardy JL, Lynn DJ, Brinkman FS, Hancock RE. Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol (2009) 30(6):249–62.10.1016/j.it.2009.03.00919428301
73. Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics (2004) 16(2):166–77.10.1152/physiolgenomics.00107.200314726599
74. Allison DB, Bassaganya-Riera J, Burlingame B, Brown AW, le Coutre J, Dickson SL, et al. Goals in nutrition Science 2015-2020. Front Nutr (2015) 2:26.10.3389/fnut.2015.00026
75. Brennan L. Metabolomics in nutrition research: current status and perspectives. Biochem Soc Trans (2013) 41(2):670–3.10.1042/BST2012035023514174
76. Bakker GC, van Erk MJ, Pellis L, Wopereis S, Rubingh CM, Cnubben NH, et al. An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am J Clin Nutr (2010) 91(4):1044–59.10.3945/ajcn.2009.2882220181810
77. Carbo A, Hontecillas R, Andrew T, Eden K, Mei Y, Hoops S, et al. Computational modeling of heterogeneity and function of CD4+ T cells. Front Cell Dev Biol (2014) 2:31.10.3389/fcell.2014.0003125364738
78. Mei Y, Abedi V, Carbo A, Zhang X, Lu P, Philipson C, et al. Multiscale modeling of mucosal immune responses. BMC Bioinformatics (2015) 16(Suppl 12):S2.10.1186/1471-2105-16-S12-S226329787
79. Wendelsdorf K, Bassaganya-Riera J, Hontecillas R, Eubank S. Model of colonic inflammation: immune modulatory mechanisms in inflammatory bowel disease. J Theor Biol (2010) 264(4):1225–39.10.1016/j.jtbi.2010.03.02720362587
80. Ghosh S, Matsuoka Y, Asai Y, Hsin KY, Kitano H. Software for systems biology: from tools to integrated platforms. Nat Rev Genet (2011) 12(12):821–32.10.1038/nrg309622048662
81. Masoudi-Nejad A, Bidkhori G, Hosseini Ashtiani S, Najafi A, Bozorgmehr JH, Wang E. Cancer systems biology and modeling: microscopic scale and multiscale approaches. Semin Cancer Biol (2015) 30C:60–9.10.1016/j.semcancer.2014.03.00324657638
82. Castiglione F, Pappalardo F, Bianca C, Russo G, Motta S. Modeling biology spanning different scales: an open challenge. Biomed Res Int (2014) 2014:902545.10.1155/2014/90254525143952
83. Dwivedi G, Fitz L, Hegen M, Martin SW, Harrold J, Heatherington A, et al. A multiscale model of interleukin-6-mediated immune regulation in Crohn’s disease and its application in drug discovery and development. CPT Pharmacometrics Syst Pharmacol (2014) 3:e89.10.1038/psp.2013.6424402116
84. Mei Y, Carbo A, Hontecillas R, Hoops S, Liles N, Pinyi L, et al. ENISI MSM: a novel multi-scale modeling platform for computational immunology. 2014 IEEE International Conference on Bioinformatics and Biomedicine. Belfast: IEEE (2014). p. 391–6.
85. Sütterlin T, Kolb C, Dickhaus H, Jäger D, Grabe N. Bridging the scales: semantic integration of quantitative SBML in graphical multi-cellular models and simulations with EPISIM and COPASI. Bioinformatics (2013) 29(2):223–9.10.1093/bioinformatics/bts65923162085
86. Mc Auley MT, Proctor CJ, Corfe BM, Cuskelly GCJ, Mooney KM. Nutrition research and the impact of computational systems biology. J Comput Sci Syst Biol (2013) 6(5):271–85.10.4172/jcsb.1000122
87. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics (2003) 19(4):524–31.10.1093/bioinformatics/btg01512611808
88. Ivanciuc O, Gendel SM, Power TD, Schein CH, Braun W. AllerML: markup language for allergens. Regul Toxicol Pharmacol (2011) 60(1):151–60.10.1016/j.yrtph.2011.03.00621420460
89. Bodenreider O. Biomedical ontologies in action: role in knowledge management, data integration and decision support. Yearb Med Inform (2008):67–79.18660879
90. Information NCFB. Medical Subject Headings. Available from: http://www.ncbi.nlm.nih.gov/mesh
91. Bodenreider O. The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res (2004) 32:D267–70.10.1093/nar/gkh06114681409
92. Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F, et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res (2012) 40(Database issue):D1128–36.10.1093/nar/gkr79721948793
93. Zhu X, Kruhlak NL. Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data. Toxicology (2014) 321:62–72.10.1016/j.tox.2014.03.00924721472
94. Liu Y, Hu B, Fu C, Chen X. DCDB: drug combination database. Bioinformatics (2010) 26(4):587–8.10.1093/bioinformatics/btp69720031966
95. Arvidson KB. FDA toxicity databases and real-time data entry. Toxicol Appl Pharmacol (2008) 233(1):17–9.10.1016/j.taap.2007.12.03318656494
96. Kelder T, Summer G, Caspers M, van Schothorst EM, Keijer J, Duivenvoorde L, et al. White adipose tissue reference network: a knowledge resource for exploring health-relevant relations. Genes Nutr (2015) 10:439.10.1007/s12263-014-0439-x25466819
97. Ramsundar B, Steven K, Patrick R, Dale W, David K, Vijay P. Massively multitask networks for drug discovery (2015). arXiv preprint arXiv:1502.02072.
98. Lu P, Abedi V, Mei Y, Hontecillas R, Hoops S, Carbo A, et al. Supervised learning methods in modeling of CD4+ T cell heterogeneity. BioData Min (2015) 8:27.10.1186/s13040-015-0060-626339293
99. Lu P, Abedi V, Mei Y, Hontecillas R, Philipson C, Hoops S, et al. Supervised learning with artificial neural network in modeling of cell differentiation process. In: Tran QN, Arabnia H, editors. Emerging Trends in Computational Biology, Bioinformatics, and Systems Biology. Burlington, MA: Elsevier (2015). 674 p.
100. Abedi V, Hoops S, Hontecillas R, Carbo A, Philipson C, Viladomiu M, et al. Computational Immunology: Models and Tools. In: Bassaganya-Riera J, editor. Boston, MA: Elsevier (2015). 210 p.
101. Philipson CW, Bassaganya-Riera J, Viladomiu M, Kronsteiner B, Abedi V, Hoops S, et al. Modeling the regulatory mechanisms by which NLRX1 modulates innate immune responses to Helicobacter pylori infection. PLoS One (2015) 10(9):e0137839.10.1371/journal.pone.013783926367386
102. Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, Awasthi A, et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature (2013) 496(7446):461–8.10.1038/nature1198123467089
103. An G, Mi Q, Dutta-Moscato J, Vodovotz Y. Agent-based models in translational systems biology. Wiley Interdiscip Rev Syst Biol Med (2009) 1(2):159–71.10.1002/wsbm.45
104. Mei Y, Hontecillas R, Xiaoying Z, Bisset K, Eubank S, Hoops S, et al. ENISI visual, an agent-based simulator for modeling gut immunity. Bioinformatics and Biomedicine (BIBM), 2012 IEEE International Conference on. Philadelphia, PA: IEEE (2012).
105. Alam M, Abedi V, Bassaganya-Riera J, Wendelsdorf K, Bisset K, Deng X, et al. Computational Immunology: Models and Tools. Boston, MA: Elsevier (2015).
106. Vida Abedi RH, Stefan H, Nathan L, Adria C, Pinyi L, Casandra P, et al. ENISI multiscale modeling of mucosal immune responses driven by high performance computing. IEEE International Conference on Bioinformatics and Biomedicine (BIBM 2015). Washington, DC (2015).
107. Bisset K, Alam MM, Bassaganya-Riera J, Carbo A, Eubank S, Hontecillas R, et al. High-performance interaction-based simulation of gut immunopathologies with enteric immunity simulator (ENISI). Parallel & Distributed Processing Symposium (IPDPS), 2012 IEEE 26th International. Shanghai: IEEE (2012).
108. Mei Y, Carbo A, Hontecillas R, Bassaganya-Riera J. ENISI SDE: a novel web-based stochastic modeling tool for computational biology. Bioinformatics and Biomedicine (BIBM), 2013 IEEE International Conference on. Shanghai: IEEE (2013).
109. Wendeldorf KV, Bassaganya-Riera J, Bisset K, Eubank S, Hontecillas R, Marathe M. Enteric immunity simulator: a tool for in silico study of gut immunopathologies. Bioinformatics and Biomedicine (BIBM), 2011 IEEE International Conference on. Atlanta, GA: IEEE (2011).
110. Wendelsdorf KV, Alam M, Bassaganya-Riera J, Bisset K, Eubank S, Hontecillas R, et al. ENteric Immunity SImulator: a tool for in silico study of gastroenteric infections. IEEE Trans Nanobioscience (2012) 11(3):273–88.10.1109/TNB.2012.221189122987134
111. Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol (2007) 152(1):9–20.10.1038/sj.bjp.070730517549047
112. Romero K, Ito K, Rogers JA, Polhamus D, Qiu R, Stephenson D, et al. The future is now: model-based clinical trial design for Alzheimer’s disease. Clin Pharmacol Ther (2015) 97(3):210–4.10.1002/cpt.16
113. Brown D, Namas RA, Almahmoud K, Zaaqoq A, Sarkar J, Barclay DA, et al. Trauma in silico: individual-specific mathematical models and virtual clinical populations. Sci Transl Med (2015) 7(285):ra61–285.10.1126/scitranslmed.aaa363625925680
114. Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature (2012) 488(7410):178–84.10.1038/nature1131922797518
115. Lu P, Bevan DR, Lewis SN, Hontecillas R, Bassaganya-Riera J. Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics. J Mol Model (2011) 17(3):543–53.10.1007/s00894-010-0748-y20512604
116. Carbo A, Hontecillas R, Cooper J, Gandour RD, Ehrich M, Bassaganya-Riera J. Mo1691 lanthionine synthetase C-like receptor 2 (LANCL2): a novel therapeutic target for inflammatory bowel disease. Gastroenterology (2015) 148(4):S–686.10.1016/S0016-5085(15)32321-0
117. Bolnick DI, Snowberg LK, Hirsch PE, Lauber CL, Org E, Parks B, et al. Individual diet has sex-dependent effects on vertebrate gut microbiota. Nat Commun (2014) 5:4500.10.1038/ncomms550025072318
118. Marx V. Biology: the big challenges of big data. Nature (2013) 498(7453):255–60.10.1038/498255a
119. Fan J, Han F, Liu H. Challenges of big data analysis. Natl Sci Rev (2014) 1(2):293–314.10.1093/nsr/nwt03225419469
120. Trelles O, Prins P, Snir M, Jansen RC. Big data, but are we ready? Nat Rev Genet (2011) 12(3):224–224.10.1038/nrg2857-c1
121. Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, et al. COPASI – a complex pathway simulator. Bioinformatics (2006) 22(24):3067–74.10.1093/bioinformatics/btl485
122. Mendes P, Stefan H, Sven S, Ralph G, Joseph D, Ursula K. Computational modeling of biochemical networks using COPASI. Systems Biology (2009):17–59.
123. Mei Y, Carbo A, Hoops S, Hontecillas R, Bassaganya-Riera J. ENISI SDE: a web-based tool for modeling stochastic processes. IEEE/ACM Trans Comput Biol Bioinform (2015) 12(2):289–97.10.1109/TCBB.2014.2351823
124. Carbo A, Hontecillas R, Kronsteiner B, Viladomiu M, Pedragosa M, Lu P, et al. Systems modeling of molecular mechanisms controlling cytokine-driven CD4+ T cell differentiation and phenotype plasticity. PLoS Comput Biol (2013) 9(4):e1003027.10.1371/journal.pcbi.100302723592971
125. Carbo A, Olivares-Villagómez D, Hontecillas R, Bassaganya-Riera J, Chaturvedi R, Piazuelo MB, et al. Systems modeling of the role of IL-21 in the maintenance of effector CD4+ T cell responses during Helicobacter pylori infection. MBio (2014) 5(4):e1243–1214.10.1128/mBio.01243-14
126. Carbo A, Bassaganya-Riera J, Pedragosa M, Viladomiu M, Marathe M, Eubank S, et al. Predictive computational modeling of the mucosal immune responses during Helicobacter pylori infection. PLoS One (2013) 8(9):e73365.10.1371/journal.pone.007336524039925
127. Kronsteiner B, Bassaganya-Riera J, Philipson C, Viladomiu M, Carbo A, Pedragosa M, et al. Helicobacter pylori infection in a pig model is dominated by Th1 and cytotoxic CD8+ T cell responses. Infect Immun (2013) 81(10):3803–13.10.1128/IAI.00660-1323897614
128. Kronsteiner B, Bassaganya-Riera J, Philipson N, Hontecillas R. Novel insights on the role of CD8+ T cells and cytotoxic responses during Helicobacter pylori infection. Gut Microbes (2014) 5(3):357–62.10.4161/gmic.2889924755940
129. Philipson CW, Bassaganya-Riera J, Hontecillas R. Animal models of enteroaggregative Escherichia coli infection. Gut Microbes (2013) 4(4):281–91.10.4161/gmic.2482623680797
130. Bolick DT, Roche JK, Hontecillas R, Bassaganya-Riera J, Nataro JP, Guerrant RL. Enteroaggregative Escherichia coli strain in a novel weaned mouse model: exacerbation by malnutrition, biofilm as a virulence factor and treatment by nitazoxanide. J Med Microbiol (2013) 62(Pt 6):896–905.10.1099/jmm.0.046300-023475903
131. Bassaganya-Riera J, Hontecillas R, Abedi V, Carbo A, Philipson C, Hoops S. Computational Immunology: Models and Tools. Boston, MA: Elsevier (2015).
132. Gorenshteyn D, Zaslavsky E, Fribourg M, Park CY, Wong AK, Tadych A, et al. Interactive big data resource to elucidate human immune pathways and diseases. Immunity (2015) 43(3):605–14.10.1016/j.immuni.2015.08.01426362267